Related Experiment Videos
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin
1Department of Laboratory Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.
Thrombosis Research
|November 15, 1996
Summary
Platelets exposed to aggregating agents remain functional, retaining key receptors like GPIb/IX. This study shows these receptors are not significantly down-regulated or cleared, even after aggregation and deaggregation cycles.
Area of Science:
- Hematology
- Platelet Biology
- Molecular Medicine
Background:
- Platelet aggregation is crucial for hemostasis but can lead to pathological states.
- The GPIb/IX receptor complex is vital for platelet adhesion and aggregation mediated by von Willebrand factor.
- Understanding receptor dynamics during platelet activation and refractoriness is key to platelet pharmacology.
Purpose of the Study:
- To investigate the surface expression of GPIb/IX receptors on platelets after exposure to potent aggregating agents.
- To determine if platelet refractoriness induced by aggregation-disaggregation cycles leads to receptor down-regulation or clearance.
- To assess the functional consequences of potential receptor changes on platelet responsiveness.
Main Methods:
- Utilized an aggregation-disaggregation-reaggregation model with platelet-rich plasma (PRP).
- Employed potent aggregating agents: thrombin, thrombin receptor activating peptide (TRAP), and U46619.
- Assessed platelet refractoriness and receptor expression using ristocetin-induced agglutination and gold particle-associated antibody analysis (GPIb/IX).
Main Results:
- Potent aggregating agents induced irreversible platelet aggregation and secretion.
- Prostaglandin E1 (PGE1) caused deaggregation, rendering platelets refractory to further stimulation.
- Refractory platelets retained sensitivity to ristocetin, indicating preserved GPIb/IX receptor function.
- Quantitative analysis revealed no significant difference in GPIb/IX receptor density between control and refractory platelets.
Conclusions:
- Exposure to potent aggregating agents does not lead to significant down-regulation or clearance of GPIb/IX receptors.
- Platelet refractoriness induced by aggregation-disaggregation cycles does not alter the surface expression of GPIb/IX.
- The GPIb/IX receptor remains accessible and functional on deaggregated, refractory platelets, suggesting preserved von Willebrand factor binding capacity.